PharmAust Limited  

(Public, ASX:PAA)   Watch this stock  
Find more results for PAA
0.010
0.000 (0.00%)
May 15 - Close
ASX data delayed by 20 mins - Disclaimer
Currency in AUD
Range     -
52 week 0.00 - 0.01
Open     -
Vol / Avg. 0.00/511,304.00
Mkt cap 5.68M
P/E     -
Div/yield     -
EPS -0.01
Shares 567.51M
Beta     -
Inst. own     -
Apr 30, 2013
Pharmaust Ltd KPI Quarterly Report - March 2013
  

Key stats and ratios

Q4 (Dec '12) 2012
Net profit margin -33.35% -262.09%
Operating margin -33.35% -262.09%
EBITD margin - -50.87%
Return on average assets -37.28% -220.78%
Return on average equity -103.91% -360.96%
Employees 52 -
Carbon Disclosure Rating - -

Address

50 Derby Road
SUBIACO, WAS 6008
Australia
+61-8-93806550 (Phone)
+61-8-93814056 (Fax)

Website links

External links

Discussion Group - Google Finance

Description

PharmAust Limited is an Australia-based drug discovery and development company. The Company operates in three segments: corporate, exploration and pharmaceutical. The corporate segment covers all the corporate overhead expenses. The exploration segment relates to the Company's operations for the exploration of tenements for minerals, oil and gas. The pharmaceutical segment provides products and services in synthetic and medicinal chemistry to the drug discovery and pharmaceutical industries. The Company develops its own drug discovery, as well as provides specialized medicinal and synthetic on a contract basis to clients. The Company�s subsidiaries include Epichem Pty Ltd, Pela Resources Pty Ltd and RI Energetika DOO Skopje. On the 19 August 2011, the Company acquired 100% interest of Pela Resources Pty Ltd.

Officers and directors

Bryant James McLarty Executive Chairman of the Board
Wayne Best Ph.D. Managing Director of Epichem Pty Ltd
John Horton Director of Epichem Pty Ltd
Colette G. Sims Director of Epichem Pty Ltd
Sam Michael Wright Company Secretary, Non-Executive Independent Director
Henry Gulev Non-Executive Independent Director